Global Tuberculosis Vaccines Market Growth 2023-2028

Report ID: 1158768 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Tuberculosis Vaccines Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Tuberculosis Vaccines by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Tuberculosis Vaccines by Country/Region, 2017, 2022 & 2028
    2.2 Tuberculosis Vaccines Segment by Type
        2.2.1 Immunotherapeutic Vaccines
        2.2.2 Booster Vaccines
        2.2.3 Others
    2.3 Tuberculosis Vaccines Sales by Type
        2.3.1 Global Tuberculosis Vaccines Sales Market Share by Type (2017-2022)
        2.3.2 Global Tuberculosis Vaccines Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Tuberculosis Vaccines Sale Price by Type (2017-2022)
    2.4 Tuberculosis Vaccines Segment by Application
        2.4.1 Hospitals
        2.4.2 Clinics
        2.4.3 Others
    2.5 Tuberculosis Vaccines Sales by Application
        2.5.1 Global Tuberculosis Vaccines Sale Market Share by Application (2017-2022)
        2.5.2 Global Tuberculosis Vaccines Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Tuberculosis Vaccines Sale Price by Application (2017-2022)
3 Global Tuberculosis Vaccines by Company
    3.1 Global Tuberculosis Vaccines Breakdown Data by Company
        3.1.1 Global Tuberculosis Vaccines Annual Sales by Company (2020-2022)
        3.1.2 Global Tuberculosis Vaccines Sales Market Share by Company (2020-2022)
    3.2 Global Tuberculosis Vaccines Annual Revenue by Company (2020-2022)
        3.2.1 Global Tuberculosis Vaccines Revenue by Company (2020-2022)
        3.2.2 Global Tuberculosis Vaccines Revenue Market Share by Company (2020-2022)
    3.3 Global Tuberculosis Vaccines Sale Price by Company
    3.4 Key Manufacturers Tuberculosis Vaccines Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Tuberculosis Vaccines Product Location Distribution
        3.4.2 Players Tuberculosis Vaccines Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tuberculosis Vaccines by Geographic Region
    4.1 World Historic Tuberculosis Vaccines Market Size by Geographic Region (2017-2022)
        4.1.1 Global Tuberculosis Vaccines Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Tuberculosis Vaccines Annual Revenue by Geographic Region
    4.2 World Historic Tuberculosis Vaccines Market Size by Country/Region (2017-2022)
        4.2.1 Global Tuberculosis Vaccines Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Tuberculosis Vaccines Annual Revenue by Country/Region
    4.3 Americas Tuberculosis Vaccines Sales Growth
    4.4 APAC Tuberculosis Vaccines Sales Growth
    4.5 Europe Tuberculosis Vaccines Sales Growth
    4.6 Middle East & Africa Tuberculosis Vaccines Sales Growth
5 Americas
    5.1 Americas Tuberculosis Vaccines Sales by Country
        5.1.1 Americas Tuberculosis Vaccines Sales by Country (2017-2022)
        5.1.2 Americas Tuberculosis Vaccines Revenue by Country (2017-2022)
    5.2 Americas Tuberculosis Vaccines Sales by Type
    5.3 Americas Tuberculosis Vaccines Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Tuberculosis Vaccines Sales by Region
        6.1.1 APAC Tuberculosis Vaccines Sales by Region (2017-2022)
        6.1.2 APAC Tuberculosis Vaccines Revenue by Region (2017-2022)
    6.2 APAC Tuberculosis Vaccines Sales by Type
    6.3 APAC Tuberculosis Vaccines Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Tuberculosis Vaccines by Country
        7.1.1 Europe Tuberculosis Vaccines Sales by Country (2017-2022)
        7.1.2 Europe Tuberculosis Vaccines Revenue by Country (2017-2022)
    7.2 Europe Tuberculosis Vaccines Sales by Type
    7.3 Europe Tuberculosis Vaccines Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Tuberculosis Vaccines by Country
        8.1.1 Middle East & Africa Tuberculosis Vaccines Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Tuberculosis Vaccines Revenue by Country (2017-2022)
    8.2 Middle East & Africa Tuberculosis Vaccines Sales by Type
    8.3 Middle East & Africa Tuberculosis Vaccines Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccines
    10.3 Manufacturing Process Analysis of Tuberculosis Vaccines
    10.4 Industry Chain Structure of Tuberculosis Vaccines
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Tuberculosis Vaccines Distributors
    11.3 Tuberculosis Vaccines Customer
12 World Forecast Review for Tuberculosis Vaccines by Geographic Region
    12.1 Global Tuberculosis Vaccines Market Size Forecast by Region
        12.1.1 Global Tuberculosis Vaccines Forecast by Region (2023-2028)
        12.1.2 Global Tuberculosis Vaccines Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Tuberculosis Vaccines Forecast by Type
    12.7 Global Tuberculosis Vaccines Forecast by Application
13 Key Players Analysis
    13.1 Sanofi
        13.1.1 Sanofi Company Information
        13.1.2 Sanofi Tuberculosis Vaccines Product Offered
        13.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Sanofi Main Business Overview
        13.1.5 Sanofi Latest Developments
    13.2 Merck
        13.2.1 Merck Company Information
        13.2.2 Merck Tuberculosis Vaccines Product Offered
        13.2.3 Merck Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Merck Main Business Overview
        13.2.5 Merck Latest Developments
    13.3 Serum Institute of India
        13.3.1 Serum Institute of India Company Information
        13.3.2 Serum Institute of India Tuberculosis Vaccines Product Offered
        13.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Serum Institute of India Main Business Overview
        13.3.5 Serum Institute of India Latest Developments
    13.4 GlaxoSmithKline
        13.4.1 GlaxoSmithKline Company Information
        13.4.2 GlaxoSmithKline Tuberculosis Vaccines Product Offered
        13.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 GlaxoSmithKline Main Business Overview
        13.4.5 GlaxoSmithKline Latest Developments
    13.5 Japan BCG Lab
        13.5.1 Japan BCG Lab Company Information
        13.5.2 Japan BCG Lab Tuberculosis Vaccines Product Offered
        13.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Japan BCG Lab Main Business Overview
        13.5.5 Japan BCG Lab Latest Developments
    13.6 IDT Biologics
        13.6.1 IDT Biologics Company Information
        13.6.2 IDT Biologics Tuberculosis Vaccines Product Offered
        13.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 IDT Biologics Main Business Overview
        13.6.5 IDT Biologics Latest Developments
    13.7 GreenSignal Bio Pharma
        13.7.1 GreenSignal Bio Pharma Company Information
        13.7.2 GreenSignal Bio Pharma Tuberculosis Vaccines Product Offered
        13.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 GreenSignal Bio Pharma Main Business Overview
        13.7.5 GreenSignal Bio Pharma Latest Developments
    13.8 Taj Pharmaceuticals
        13.8.1 Taj Pharmaceuticals Company Information
        13.8.2 Taj Pharmaceuticals Tuberculosis Vaccines Product Offered
        13.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Taj Pharmaceuticals Main Business Overview
        13.8.5 Taj Pharmaceuticals Latest Developments
    13.9 Bavarian Nordic
        13.9.1 Bavarian Nordic Company Information
        13.9.2 Bavarian Nordic Tuberculosis Vaccines Product Offered
        13.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Bavarian Nordic Main Business Overview
        13.9.5 Bavarian Nordic Latest Developments
    13.10 China National Biotec Group
        13.10.1 China National Biotec Group Company Information
        13.10.2 China National Biotec Group Tuberculosis Vaccines Product Offered
        13.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 China National Biotec Group Main Business Overview
        13.10.5 China National Biotec Group Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Tuberculosis Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Tuberculosis Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Immunotherapeutic Vaccines
    Table 4. Major Players of Booster Vaccines
    Table 5. Major Players of Others
    Table 6. Global Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 7. Global Tuberculosis Vaccines Sales Market Share by Type (2017-2022)
    Table 8. Global Tuberculosis Vaccines Revenue by Type (2017-2022) & ($ million)
    Table 9. Global Tuberculosis Vaccines Revenue Market Share by Type (2017-2022)
    Table 10. Global Tuberculosis Vaccines Sale Price by Type (2017-2022) & (USD/Dose)
    Table 11. Global Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 12. Global Tuberculosis Vaccines Sales Market Share by Application (2017-2022)
    Table 13. Global Tuberculosis Vaccines Revenue by Application (2017-2022)
    Table 14. Global Tuberculosis Vaccines Revenue Market Share by Application (2017-2022)
    Table 15. Global Tuberculosis Vaccines Sale Price by Application (2017-2022) & (USD/Dose)
    Table 16. Global Tuberculosis Vaccines Sales by Company (2020-2022) & (K Doses)
    Table 17. Global Tuberculosis Vaccines Sales Market Share by Company (2020-2022)
    Table 18. Global Tuberculosis Vaccines Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global Tuberculosis Vaccines Revenue Market Share by Company (2020-2022)
    Table 20. Global Tuberculosis Vaccines Sale Price by Company (2020-2022) & (USD/Dose)
    Table 21. Key Manufacturers Tuberculosis Vaccines Producing Area Distribution and Sales Area
    Table 22. Players Tuberculosis Vaccines Products Offered
    Table 23. Tuberculosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Tuberculosis Vaccines Sales by Geographic Region (2017-2022) & (K Doses)
    Table 27. Global Tuberculosis Vaccines Sales Market Share Geographic Region (2017-2022)
    Table 28. Global Tuberculosis Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global Tuberculosis Vaccines Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global Tuberculosis Vaccines Sales by Country/Region (2017-2022) & (K Doses)
    Table 31. Global Tuberculosis Vaccines Sales Market Share by Country/Region (2017-2022)
    Table 32. Global Tuberculosis Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global Tuberculosis Vaccines Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 35. Americas Tuberculosis Vaccines Sales Market Share by Country (2017-2022)
    Table 36. Americas Tuberculosis Vaccines Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas Tuberculosis Vaccines Revenue Market Share by Country (2017-2022)
    Table 38. Americas Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 39. Americas Tuberculosis Vaccines Sales Market Share by Type (2017-2022)
    Table 40. Americas Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 41. Americas Tuberculosis Vaccines Sales Market Share by Application (2017-2022)
    Table 42. APAC Tuberculosis Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 43. APAC Tuberculosis Vaccines Sales Market Share by Region (2017-2022)
    Table 44. APAC Tuberculosis Vaccines Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC Tuberculosis Vaccines Revenue Market Share by Region (2017-2022)
    Table 46. APAC Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 47. APAC Tuberculosis Vaccines Sales Market Share by Type (2017-2022)
    Table 48. APAC Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 49. APAC Tuberculosis Vaccines Sales Market Share by Application (2017-2022)
    Table 50. Europe Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 51. Europe Tuberculosis Vaccines Sales Market Share by Country (2017-2022)
    Table 52. Europe Tuberculosis Vaccines Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe Tuberculosis Vaccines Revenue Market Share by Country (2017-2022)
    Table 54. Europe Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 55. Europe Tuberculosis Vaccines Sales Market Share by Type (2017-2022)
    Table 56. Europe Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 57. Europe Tuberculosis Vaccines Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 59. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa Tuberculosis Vaccines Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa Tuberculosis Vaccines Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 63. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 65. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of Tuberculosis Vaccines
    Table 67. Key Market Challenges & Risks of Tuberculosis Vaccines
    Table 68. Key Industry Trends of Tuberculosis Vaccines
    Table 69. Tuberculosis Vaccines Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Tuberculosis Vaccines Distributors List
    Table 72. Tuberculosis Vaccines Customer List
    Table 73. Global Tuberculosis Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
    Table 74. Global Tuberculosis Vaccines Sales Market Forecast by Region
    Table 75. Global Tuberculosis Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global Tuberculosis Vaccines Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas Tuberculosis Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
    Table 78. Americas Tuberculosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC Tuberculosis Vaccines Sales Forecast by Region (2023-2028) & (K Doses)
    Table 80. APAC Tuberculosis Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe Tuberculosis Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
    Table 82. Europe Tuberculosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa Tuberculosis Vaccines Sales Forecast by Country (2023-2028) & (K Doses)
    Table 84. Middle East & Africa Tuberculosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global Tuberculosis Vaccines Sales Forecast by Type (2023-2028) & (K Doses)
    Table 86. Global Tuberculosis Vaccines Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global Tuberculosis Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global Tuberculosis Vaccines Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global Tuberculosis Vaccines Sales Forecast by Application (2023-2028) & (K Doses)
    Table 90. Global Tuberculosis Vaccines Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global Tuberculosis Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global Tuberculosis Vaccines Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Sanofi Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 94. Sanofi Tuberculosis Vaccines Product Offered
    Table 95. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 96. Sanofi Main Business
    Table 97. Sanofi Latest Developments
    Table 98. Merck Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 99. Merck Tuberculosis Vaccines Product Offered
    Table 100. Merck Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 101. Merck Main Business
    Table 102. Merck Latest Developments
    Table 103. Serum Institute of India Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 104. Serum Institute of India Tuberculosis Vaccines Product Offered
    Table 105. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 106. Serum Institute of India Main Business
    Table 107. Serum Institute of India Latest Developments
    Table 108. GlaxoSmithKline Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 109. GlaxoSmithKline Tuberculosis Vaccines Product Offered
    Table 110. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 111. GlaxoSmithKline Main Business
    Table 112. GlaxoSmithKline Latest Developments
    Table 113. Japan BCG Lab Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 114. Japan BCG Lab Tuberculosis Vaccines Product Offered
    Table 115. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 116. Japan BCG Lab Main Business
    Table 117. Japan BCG Lab Latest Developments
    Table 118. IDT Biologics Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 119. IDT Biologics Tuberculosis Vaccines Product Offered
    Table 120. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 121. IDT Biologics Main Business
    Table 122. IDT Biologics Latest Developments
    Table 123. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 124. GreenSignal Bio Pharma Tuberculosis Vaccines Product Offered
    Table 125. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 126. GreenSignal Bio Pharma Main Business
    Table 127. GreenSignal Bio Pharma Latest Developments
    Table 128. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 129. Taj Pharmaceuticals Tuberculosis Vaccines Product Offered
    Table 130. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 131. Taj Pharmaceuticals Main Business
    Table 132. Taj Pharmaceuticals Latest Developments
    Table 133. Bavarian Nordic Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 134. Bavarian Nordic Tuberculosis Vaccines Product Offered
    Table 135. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 136. Bavarian Nordic Main Business
    Table 137. Bavarian Nordic Latest Developments
    Table 138. China National Biotec Group Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 139. China National Biotec Group Tuberculosis Vaccines Product Offered
    Table 140. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 141. China National Biotec Group Main Business
    Table 142. China National Biotec Group Latest Developments
List of Figures
    Figure 1. Picture of Tuberculosis Vaccines
    Figure 2. Tuberculosis Vaccines Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Tuberculosis Vaccines Sales Growth Rate 2017-2028 (K Doses)
    Figure 7. Global Tuberculosis Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Tuberculosis Vaccines Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Immunotherapeutic Vaccines
    Figure 10. Product Picture of Booster Vaccines
    Figure 11. Product Picture of Others
    Figure 12. Global Tuberculosis Vaccines Sales Market Share by Type in 2021
    Figure 13. Global Tuberculosis Vaccines Revenue Market Share by Type (2017-2022)
    Figure 14. Tuberculosis Vaccines Consumed in Hospitals
    Figure 15. Global Tuberculosis Vaccines Market: Hospitals (2017-2022) & (K Doses)
    Figure 16. Tuberculosis Vaccines Consumed in Clinics
    Figure 17. Global Tuberculosis Vaccines Market: Clinics (2017-2022) & (K Doses)
    Figure 18. Tuberculosis Vaccines Consumed in Others
    Figure 19. Global Tuberculosis Vaccines Market: Others (2017-2022) & (K Doses)
    Figure 20. Global Tuberculosis Vaccines Sales Market Share by Application (2017-2022)
    Figure 21. Global Tuberculosis Vaccines Revenue Market Share by Application in 2021
    Figure 22. Tuberculosis Vaccines Revenue Market by Company in 2021 ($ Million)
    Figure 23. Global Tuberculosis Vaccines Revenue Market Share by Company in 2021
    Figure 24. Global Tuberculosis Vaccines Sales Market Share by Geographic Region (2017-2022)
    Figure 25. Global Tuberculosis Vaccines Revenue Market Share by Geographic Region in 2021
    Figure 26. Global Tuberculosis Vaccines Sales Market Share by Region (2017-2022)
    Figure 27. Global Tuberculosis Vaccines Revenue Market Share by Country/Region in 2021
    Figure 28. Americas Tuberculosis Vaccines Sales 2017-2022 (K Doses)
    Figure 29. Americas Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)
    Figure 30. APAC Tuberculosis Vaccines Sales 2017-2022 (K Doses)
    Figure 31. APAC Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)
    Figure 32. Europe Tuberculosis Vaccines Sales 2017-2022 (K Doses)
    Figure 33. Europe Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)
    Figure 34. Middle East & Africa Tuberculosis Vaccines Sales 2017-2022 (K Doses)
    Figure 35. Middle East & Africa Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)
    Figure 36. Americas Tuberculosis Vaccines Sales Market Share by Country in 2021
    Figure 37. Americas Tuberculosis Vaccines Revenue Market Share by Country in 2021
    Figure 38. United States Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Canada Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Mexico Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Brazil Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 42. APAC Tuberculosis Vaccines Sales Market Share by Region in 2021
    Figure 43. APAC Tuberculosis Vaccines Revenue Market Share by Regions in 2021
    Figure 44. China Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Japan Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 46. South Korea Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Southeast Asia Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 48. India Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Australia Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Europe Tuberculosis Vaccines Sales Market Share by Country in 2021
    Figure 51. Europe Tuberculosis Vaccines Revenue Market Share by Country in 2021
    Figure 52. Germany Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 53. France Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 54. UK Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Italy Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Russia Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Country in 2021
    Figure 58. Middle East & Africa Tuberculosis Vaccines Revenue Market Share by Country in 2021
    Figure 59. Egypt Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 60. South Africa Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Israel Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Turkey Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 63. GCC Country Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Manufacturing Cost Structure Analysis of Tuberculosis Vaccines in 2021
    Figure 65. Manufacturing Process Analysis of Tuberculosis Vaccines
    Figure 66. Industry Chain Structure of Tuberculosis Vaccines
    Figure 67. Channels of Distribution
    Figure 68. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Tuberculosis Vaccines Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Tuberculosis Vaccines Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Tuberculosis Vaccines Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports